Metabolomics and correlation network analysis of follicular fluid reveals associations between l‐tryptophan, l‐tyrosine and polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation ana...
Saved in:
Published in | Biomedical chromatography Vol. 35; no. 3; pp. e4993 - n/a |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
01.03.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0269-3879 1099-0801 1099-0801 |
DOI | 10.1002/bmc.4993 |
Cover
Loading…
Abstract | Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation analysis of metabolites is sparse. Accordingly, in this study, we aimed to examine metabolic differences owing to the pathogenesis of PCOS, identify the hub metabolites and investigate its associations with androgens. We applied GC–MS platform coupled with a correlation network approach to analyze follicular fluid samples from 32 PCOS patients without obesity and IR and 31 healthy women. Thirty significantly altered metabolites in PCOS patients were enriched in amino acid metabolism. l‐Phenylalanine, l‐tryptophan, pyroglutamic acid, l‐tyrosine, l‐leucine and l‐valine were screened as hub metabolites in metabolic correlation network. Among them, increased l‐tryptophan and l‐tyrosine were altered hub metabolites, and they had a more significant impact on the metabolic change of PCOS. In addition, l‐tryptophan and l‐tyrosine were significantly positively associated with serum androgens levels in the PCOS. Our results suggest that disorders of amino acid metabolism, especially tryptophan and tyrosine metabolism, might play an important role in the development of PCOS in predisposed women without obesity and IR. |
---|---|
AbstractList | Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation analysis of metabolites is sparse. Accordingly, in this study, we aimed to examine metabolic differences owing to the pathogenesis of PCOS, identify the hub metabolites and investigate its associations with androgens. We applied GC-MS platform coupled with a correlation network approach to analyze follicular fluid samples from 32 PCOS patients without obesity and IR and 31 healthy women. Thirty significantly altered metabolites in PCOS patients were enriched in amino acid metabolism. l-Phenylalanine, l-tryptophan, pyroglutamic acid, l-tyrosine, l-leucine and l-valine were screened as hub metabolites in metabolic correlation network. Among them, increased l-tryptophan and l-tyrosine were altered hub metabolites, and they had a more significant impact on the metabolic change of PCOS. In addition, l-tryptophan and l-tyrosine were significantly positively associated with serum androgens levels in the PCOS. Our results suggest that disorders of amino acid metabolism, especially tryptophan and tyrosine metabolism, might play an important role in the development of PCOS in predisposed women without obesity and IR.Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation analysis of metabolites is sparse. Accordingly, in this study, we aimed to examine metabolic differences owing to the pathogenesis of PCOS, identify the hub metabolites and investigate its associations with androgens. We applied GC-MS platform coupled with a correlation network approach to analyze follicular fluid samples from 32 PCOS patients without obesity and IR and 31 healthy women. Thirty significantly altered metabolites in PCOS patients were enriched in amino acid metabolism. l-Phenylalanine, l-tryptophan, pyroglutamic acid, l-tyrosine, l-leucine and l-valine were screened as hub metabolites in metabolic correlation network. Among them, increased l-tryptophan and l-tyrosine were altered hub metabolites, and they had a more significant impact on the metabolic change of PCOS. In addition, l-tryptophan and l-tyrosine were significantly positively associated with serum androgens levels in the PCOS. Our results suggest that disorders of amino acid metabolism, especially tryptophan and tyrosine metabolism, might play an important role in the development of PCOS in predisposed women without obesity and IR. Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation analysis of metabolites is sparse. Accordingly, in this study, we aimed to examine metabolic differences owing to the pathogenesis of PCOS, identify the hub metabolites and investigate its associations with androgens. We applied GC–MS platform coupled with a correlation network approach to analyze follicular fluid samples from 32 PCOS patients without obesity and IR and 31 healthy women. Thirty significantly altered metabolites in PCOS patients were enriched in amino acid metabolism. l‐Phenylalanine, l‐tryptophan, pyroglutamic acid, l‐tyrosine, l‐leucine and l‐valine were screened as hub metabolites in metabolic correlation network. Among them, increased l‐tryptophan and l‐tyrosine were altered hub metabolites, and they had a more significant impact on the metabolic change of PCOS. In addition, l‐tryptophan and l‐tyrosine were significantly positively associated with serum androgens levels in the PCOS. Our results suggest that disorders of amino acid metabolism, especially tryptophan and tyrosine metabolism, might play an important role in the development of PCOS in predisposed women without obesity and IR. Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation analysis of metabolites is sparse. Accordingly, in this study, we aimed to examine metabolic differences owing to the pathogenesis of PCOS, identify the hub metabolites and investigate its associations with androgens. We applied GC–MS platform coupled with a correlation network approach to analyze follicular fluid samples from 32 PCOS patients without obesity and IR and 31 healthy women. Thirty significantly altered metabolites in PCOS patients were enriched in amino acid metabolism. l ‐Phenylalanine, l ‐tryptophan, pyroglutamic acid, l ‐tyrosine, l ‐leucine and l ‐valine were screened as hub metabolites in metabolic correlation network. Among them, increased l ‐tryptophan and l ‐tyrosine were altered hub metabolites, and they had a more significant impact on the metabolic change of PCOS. In addition, l ‐tryptophan and l ‐tyrosine were significantly positively associated with serum androgens levels in the PCOS. Our results suggest that disorders of amino acid metabolism, especially tryptophan and tyrosine metabolism, might play an important role in the development of PCOS in predisposed women without obesity and IR. |
Author | Qiao, Jie Zhao, Yue Hang, Jing Hou, Entai |
Author_xml | – sequence: 1 givenname: Entai orcidid: 0000-0002-0596-7195 surname: Hou fullname: Hou, Entai organization: Key Laboratory of Assisted Reproduction (Peking University) – sequence: 2 givenname: Yue surname: Zhao fullname: Zhao, Yue organization: Key Laboratory of Assisted Reproduction (Peking University) – sequence: 3 givenname: Jing surname: Hang fullname: Hang, Jing email: hang1124jing@163.com organization: Key Laboratory of Assisted Reproduction (Peking University) – sequence: 4 givenname: Jie orcidid: 0000-0003-2126-1376 surname: Qiao fullname: Qiao, Jie email: jie.qiao@263.net organization: Key Laboratory of Assisted Reproduction (Peking University) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32986877$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1uFDEQhS2UiEwCEidAXrKgJ2W7f-wljPiTEmUT1pbb7RYGt93Y7kS9yxHYcj1OgjOTwAZWJZe-96pc7xQd-eANQi8IbAkAPe8nva2FYE_QhoAQFXAgR2gDtBUV4504QacpfQUA0dLuKTphVPCWd90G_bw0WfXBhcnqhJUfsA4xGqeyDR57k29D_Fb6yq3JJhxGPAbnrF6cinh0ix1wNDdGuSJOKWi7FybcF6UxHrtfdz9yXOcc5i_Kvz681xiS9WY_bg5u1WvKVuNwo-KK0-qHGCbzDB2PxdY8f6hn6PP7d9e7j9XF1YdPuzcXlWaUsKqreyM63uuaM2g4byihqtVAa-C17tqBad60NdHABOWatoWiIGBshAIGjJ2hVwffOYbvi0lZTjZp45zyJixJ0rruGGkIowV9-YAu_WQGOUc7lZXl4zkLsD0AuvwwRTNKbfP-Ijkq6yQBeZ-XLHnJ-7z-Dv8jePT8B1od0FvrzPpfTr693O3537nSqAI |
CitedBy_id | crossref_primary_10_1016_j_rbmo_2023_103762 crossref_primary_10_1055_s_0041_1729841 crossref_primary_10_3389_fendo_2024_1426517 crossref_primary_10_7759_cureus_71199 crossref_primary_10_1016_j_taap_2024_117187 crossref_primary_10_3390_metabo11090623 crossref_primary_10_1016_j_foodres_2024_114138 crossref_primary_10_1093_toxres_tfae169 crossref_primary_10_3390_biom14080918 crossref_primary_10_1016_j_jpba_2023_115602 crossref_primary_10_1080_10408363_2024_2430775 crossref_primary_10_1186_s12967_024_04952_y crossref_primary_10_1016_j_mce_2024_112381 crossref_primary_10_3389_fendo_2024_1354214 crossref_primary_10_1177_11786469221099214 crossref_primary_10_1096_fj_202400453R crossref_primary_10_1016_j_clnesp_2024_11_013 crossref_primary_10_1002_bmc_5500 crossref_primary_10_3390_ijms22168735 crossref_primary_10_3390_nu15194153 crossref_primary_10_1155_2022_6877541 crossref_primary_10_1007_s11694_023_02283_y crossref_primary_10_3389_fcell_2021_777224 crossref_primary_10_3389_fendo_2021_747944 crossref_primary_10_1016_j_ab_2022_114665 crossref_primary_10_1007_s10815_022_02647_1 crossref_primary_10_3390_biomedicines10112852 crossref_primary_10_3390_ijms25094977 crossref_primary_10_1186_s12964_023_01410_y crossref_primary_10_3390_separations9110329 crossref_primary_10_1007_s00210_023_02750_9 crossref_primary_10_3390_biomedicines10061254 crossref_primary_10_1016_j_microc_2023_108938 |
Cites_doi | 10.1080/09513590.2019.1576616 10.1152/ajpendo.00401.2018 10.1373/clinchem.2011.176396 10.1016/j.cca.2019.11.016 10.1186/1471-2105-8-207 10.1038/nature11986 10.1021/ac402503m 10.1016/j.metabol.2015.01.008 10.1038/nrg2918 10.1111/cen.14056 10.1021/ac202828r 10.1109/TVCG.2015.2467771 10.1007/s00018-007-7053-7 10.1186/1741-7015-10-153 10.1016/j.mcna.2014.09.003 10.1186/1471-2393-14-11 10.1210/er.2015-1104 10.1353/pbm.1970.0001 10.1186/1752-0509-8-6 10.1038/s41573-019-0016-5 10.1016/j.metabol.2017.03.002 10.1016/j.fertnstert.2019.01.028 10.1055/s-0032-1328878 10.1186/s12863-015-0259-z 10.1016/j.fertnstert.2004.11.070 10.1016/j.aca.2014.11.009 10.1016/j.febslet.2009.03.001 10.1016/j.freeradbiomed.2015.05.013 10.1021/ac051495j 10.1210/jc.2012-1382 10.1038/nm.2307 10.1007/s10815-013-0004-3 10.1016/j.mce.2017.06.026 10.1186/1752-0509-5-1 10.1097/MD.0000000000004526 10.1186/cc3818 10.1002/bmc.4133 10.1038/ki.2010.333 10.1016/j.metabol.2018.11.002 10.1016/j.bbrc.2014.06.089 10.1210/jcem.87.2.8199 10.1016/j.jsbmb.2018.08.008 10.1186/1477-7827-9-7 10.1097/GRF.0b013e31802f54c8 10.1186/s12958-019-0490-y 10.1530/EJE-14-0253 10.1038/s41591-019-0509-0 10.1021/pr3000317 10.1016/j.fertnstert.2008.09.070 10.1093/humupd/dmq001 |
ContentType | Journal Article |
Copyright | 2020 John Wiley & Sons, Ltd. |
Copyright_xml | – notice: 2020 John Wiley & Sons, Ltd. |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1002/bmc.4993 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Chemistry |
EISSN | 1099-0801 |
EndPage | n/a |
ExternalDocumentID | 32986877 10_1002_bmc_4993 BMC4993 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China funderid: 31800624; 82071658 – fundername: National Key Research and Development Program of China funderid: 2018YFC1004403; 2018YFC1003702 – fundername: Beijing Nova Program funderid: Z201100006820010 – fundername: Key Clinical Program of Peking University Third Hospital funderid: BYSY2017031 – fundername: Beijing Nova Program grantid: Z201100006820010 – fundername: National Natural Science Foundation of China grantid: 82071658 – fundername: National Key Research and Development Program of China grantid: 2018YFC1003702 – fundername: Key Clinical Program of Peking University Third Hospital grantid: BYSY2017031 – fundername: National Key Research and Development Program of China grantid: 2018YFC1004403 – fundername: National Natural Science Foundation of China grantid: 31800624 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 23N 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AQPKS ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HF~ HGLYW HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LH5 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ O66 O9- OIG P2P P2W P2X P4D PALCI Q.N Q11 QB0 QRW R.K RIWAO RJQFR RNS ROL RWI RX1 RYL SAMSI SUPJJ SV3 UB1 V2E W8V W99 WBFHL WBKPD WIB WIH WIK WJL WOHZO WQJ WRC WRJ WXSBR WYISQ XG1 XPP XV2 ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY |
ID | FETCH-LOGICAL-c3213-74be978bc48305885212a6c024084c76d3c85641c03928c263052090f59a03033 |
IEDL.DBID | DR2 |
ISSN | 0269-3879 1099-0801 |
IngestDate | Fri Jul 11 08:58:37 EDT 2025 Wed Feb 19 02:28:52 EST 2025 Tue Jul 01 03:41:57 EDT 2025 Thu Apr 24 23:03:09 EDT 2025 Wed Jan 22 16:31:14 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | l-tyrosine PCOS network analysis l-tryptophan amino acid metabolism |
Language | English |
License | 2020 John Wiley & Sons, Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3213-74be978bc48305885212a6c024084c76d3c85641c03928c263052090f59a03033 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-0596-7195 0000-0003-2126-1376 |
PMID | 32986877 |
PQID | 2447315132 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | proquest_miscellaneous_2447315132 pubmed_primary_32986877 crossref_citationtrail_10_1002_bmc_4993 crossref_primary_10_1002_bmc_4993 wiley_primary_10_1002_bmc_4993_BMC4993 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | March 2021 2021-03-00 2021-Mar 20210301 |
PublicationDateYYYYMMDD | 2021-03-01 |
PublicationDate_xml | – month: 03 year: 2021 text: March 2021 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Biomedical chromatography |
PublicationTitleAlternate | Biomed Chromatogr |
PublicationYear | 2021 |
References | 2019; 91 2010; 16 2019; 92 2006; 78 2015; 854C 2019; 17 2019; 18 2011; 12 2014; 171 2012; 58 2011; 17 2016; 37 2012; 11 2014; 450 2012; 10 2012; 97 2017; 71 2009; 91 2015; 86 2002; 87 2019; 25 2007; 8 2014; 14 2019; 316 2007; 64 2014; 8 2018; 32 2019; 111 2010; 78 2015; 16 2019; 35 2018; 465 2015; 11 2015; 99 2013; 85 2016; 95 2007; 50 2019; 502 2005; 83 2019; 185 2011; 5 1970; 14 2012; 30 2011; 9 2015; 64 2005; 9 2013; 30 2009; 583 2013; 496 2016; 22 2012; 84 e_1_2_10_23_1 e_1_2_10_46_1 e_1_2_10_21_1 e_1_2_10_44_1 e_1_2_10_42_1 e_1_2_10_40_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_39_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_30_1 e_1_2_10_51_1 e_1_2_10_29_1 e_1_2_10_27_1 e_1_2_10_25_1 e_1_2_10_48_1 e_1_2_10_24_1 e_1_2_10_45_1 Kanazawa M. (e_1_2_10_20_1) 2015; 11 e_1_2_10_22_1 e_1_2_10_43_1 e_1_2_10_41_1 e_1_2_10_52_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_9_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_31_1 e_1_2_10_50_1 e_1_2_10_28_1 e_1_2_10_49_1 e_1_2_10_26_1 e_1_2_10_47_1 |
References_xml | – volume: 5 start-page: 1 issue: 1 year: 2011 end-page: 12 article-title: Metabolomic correlation‐network modules in based on a graph‐clustering approach publication-title: BMC Systems Biology – volume: 450 start-page: 863 issue: 1 year: 2014 end-page: 869 article-title: Analysis of metabolites in plasma reveals distinct metabolic features between Dahl salt‐sensitive rats and consomic SS.13(BN) rats publication-title: Biochemical and Biophysical Research Communications – volume: 502 start-page: 280 year: 2019 end-page: 286 article-title: Metabolic alterations associated with polycystic ovary syndrome: A UPLC Q‐exactive based metabolomic study publication-title: Clinica Chimica Acta – volume: 87 start-page: 742 issue: 2 year: 2002 end-page: 746 article-title: Altered vascular function in young women with polycystic ovary syndrome publication-title: The Journal of Clinical Endocrinology & Metabolism – volume: 12 start-page: 56 issue: 1 year: 2011 end-page: 68 article-title: Network medicine: A network‐based approach to human disease publication-title: Nature Reviews Genetics – volume: 97 start-page: 3,709 issue: 10 year: 2012 end-page: 3,716 article-title: Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance publication-title: The Journal of Clinical Endocrinology & Metabolism – volume: 14 start-page: 154 issue: 1 year: 1970 end-page: 170 article-title: The history of the tricarboxylic acid cycle publication-title: Perspectives in Biology and Medicine – volume: 95 issue: 36 year: 2016 article-title: Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta‐analysis publication-title: Medicine (Baltimore) – volume: 18 start-page: 379 year: 2019 end-page: 401 article-title: Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond publication-title: Nature Reviews Drug Discovery – volume: 58 start-page: 999 issue: 6 year: 2012 end-page: 1009 article-title: Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: Plasma metabolomic approach using GC–MS publication-title: Clinical Chemistry – volume: 465 start-page: 36 year: 2018 end-page: 47 article-title: Role of androgens in the ovary publication-title: Molecular and Cellular Endocrinology – volume: 9 start-page: 7 year: 2011 article-title: Is interleukin‐18 associated with polycystic ovary syndrome? publication-title: Reproductive Biology and Endocrinology – volume: 316 start-page: E383 issue: 3 year: 2019 end-page: e396 article-title: Obesity leads to distinct metabolomic signatures in follicular fluid of women undergoing in vitro fertilization publication-title: American Journal of Physiology. Endocrinology and Metabolism – volume: 11 start-page: S732 issue: s8 year: 2015 end-page: S737 article-title: Criteria and classification of obesity in Japan and Asia–Oceania publication-title: Asia Pacific Journal of Clinical Nutrition – volume: 11 start-page: 2,937 issue: 5 year: 2012 end-page: 2,946 article-title: Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients publication-title: Journal of Proteome Research – volume: 64 start-page: 720 issue: 6 year: 2015 end-page: 728 article-title: Effect of insulin sensitizer therapy on amino acids and their metabolites publication-title: Metabolism – volume: 35 start-page: 463 issue: 6 year: 2019 end-page: 469 article-title: Potential roles of carnitine in patients with polycystic ovary syndrome: A systematic review publication-title: Gynecological Endocrinology – volume: 17 start-page: 448 issue: 4 year: 2011 end-page: 453 article-title: Metabolite profiles and the risk of developing diabetes publication-title: Nature Medicine – volume: 78 start-page: 567 issue: 78 year: 2006 end-page: 574 article-title: Large‐scale human metabolomics studies: A strategy for data (pre‐) processing and validation publication-title: Analytical Chemistry – volume: 496 start-page: 238 issue: 7444 year: 2013 end-page: 242 article-title: Succinate is an inflammatory signal that induces IL‐1β through HIF‐1 publication-title: Nature – volume: 16 start-page: 347 issue: 4 year: 2010 end-page: 363 article-title: Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta‐analysis publication-title: Human Reproduction Update – volume: 9 start-page: 588 issue: 6 year: 2005 end-page: 593 article-title: Lactate as a marker of energy failure in critically ill patients: Hypothesis publication-title: Critical Care – volume: 32 issue: 4 year: 2018 article-title: Combined metabolomic and correlation networks analyses reveal fumarase insufficiency altered amino acids metabolism publication-title: Biomedical Chromatography – volume: 86 start-page: 295 year: 2015 end-page: 307 article-title: Metabolism alteration in follicular niche: The nexus among intermediary metabolism, mitochondrial function, and classic polycystic ovary syndrome publication-title: Free Radical Biology & Medicine – volume: 92 start-page: 108 year: 2019 end-page: 120 article-title: Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics publication-title: Metabolism – volume: 50 start-page: 277 issue: 1 year: 2007 end-page: 294 article-title: Obesity and lifestyle management in polycystic ovary syndrome publication-title: Clinical Obstetrics and Gynecology – volume: 25 start-page: 1,225 issue: 8 year: 2019 end-page: 1,233 article-title: Gut microbiota–bile acid–interleukin‐22 axis orchestrates polycystic ovary syndrome publication-title: Nature Medicine – volume: 583 start-page: 1759 year: 2009 end-page: 1765 article-title: A network base approach to human disease publication-title: FEBS Letters – volume: 84 start-page: 428 issue: 1 year: 2012 end-page: 439 article-title: Pattern recognition approaches and computational systems tools for ultra performance liquid chromatography–mass spectrometry‐based comprehensive metabolomic profiling and pathways analysis of biological data sets publication-title: Analytical Chemistry – volume: 71 start-page: 52 year: 2017 end-page: 63 article-title: Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome publication-title: Metabolism – volume: 78 start-page: 1,214 issue: 12 year: 2010 end-page: 1,217 article-title: High glucose and renin release: The role of succinate and GPR91 publication-title: Kidney International – volume: 37 start-page: 467 issue: 5 year: 2016 end-page: 520 article-title: The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited publication-title: Endocrine Reviews – volume: 14 issue: 1 year: 2014 article-title: Metabolic heterogeneity of follicular amino acids in polycystic ovary syndrome is affected by obesity and related to pregnancy outcome publication-title: Bmc Pregnancy & Childbirth – volume: 83 start-page: 1,454 issue: 5 year: 2005 end-page: 1,460 article-title: Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment publication-title: Fertility & Sterility – volume: 10 issue: 1 year: 2012 article-title: Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: Plasma metabolomics analysis publication-title: BMC Medicine – volume: 17 issue: 1 year: 2019 article-title: Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry publication-title: Reproductive Biology and Endocrinology – volume: 111 start-page: 471 issue: 3 year: 2019 end-page: 472 article-title: Polycystic ovary syndrome: A reproductive and metabolic web of risk, comorbidities, and disease publication-title: Fertility and Sterility – volume: 22 start-page: 160 issue: 1 year: 2016 end-page: 169 article-title: TrajGraph: A graph‐based visual analytics approach to studying urban network centralities using taxi trajectory data publication-title: IEEE Transactions on Visualization and Computer Graphics – volume: 8 start-page: 6 year: 2014 article-title: Protein interaction networks as metric spaces: A novel perspective on distribution of hubs publication-title: BMC Systems Biology – volume: 91 start-page: 1,563 issue: 4 Suppl year: 2009 end-page: 1,567 article-title: Long‐term consequences of polycystic ovary syndrome on cardiovascular risk publication-title: Fertility and Sterility – volume: 85 start-page: 11,725 issue: 24 year: 2013 end-page: 11,731 article-title: Metabolite profiling of a NIST standard reference material for human plasma (SRM 1950): GC–MS, LC–MS, NMR, and clinical laboratory analyses, libraries, and web‐based resources publication-title: Analytical Chemistry – volume: 91 start-page: 508 issue: 4 year: 2019 end-page: 516 article-title: Changes in whole metabolites after exenatide treatment in overweight/obese polycystic ovary syndrome patients publication-title: Clinical Endocrinology – volume: 171 start-page: 1 issue: 4 year: 2014 end-page: 29 article-title: The polycystic ovary syndrome: An endocrinological perspective from the European Society of Endocrinology publication-title: European Journal of Endocrinology – volume: 16 year: 2015 article-title: Importance of presenting the variability of the false discovery rate control publication-title: BMC Genetics – volume: 185 start-page: 142 year: 2019 end-page: 149 article-title: Follicular dynamics of glycerophospholipid and sphingolipid metabolisms in polycystic ovary syndrome patients publication-title: The Journal of Steroid Biochemistry and Molecular Biology – volume: 854C start-page: 95 year: 2015 end-page: 105 article-title: Reconstruction and analysis of correlation networks based on GC–MS metabolomics data for young hypertensive men publication-title: Analytica Chimica Acta – volume: 64 start-page: 1739 issue: 14 year: 2007 end-page: 1751 article-title: Network analysis approach for biology publication-title: Cellular and Molecular Life Sciences – volume: 30 start-page: 1,231 issue: 9 year: 2013 end-page: 1,238 article-title: A proteomic analysis of human follicular fluid: Comparison between fertilized oocytes and non‐fertilized oocytes in the same patient publication-title: Journal of Assisted Reproduction and Genetics – volume: 8 start-page: 207 issue: 1 year: 2007 article-title: Orthogonal projections to latent structures as a strategy for microarray data normalization publication-title: BMC Bioinformatics – volume: 30 start-page: 496 issue: 6 year: 2012 end-page: 506 article-title: Obesity and PCOS: Implications for diagnosis and treatment publication-title: Seminars in Reproductive Medicine – volume: 99 start-page: 221 issue: 1 year: 2015 end-page: 235 article-title: Polycystic ovarian syndrome publication-title: The Medical Clinics of North America – ident: e_1_2_10_27_1 doi: 10.1080/09513590.2019.1576616 – ident: e_1_2_10_34_1 doi: 10.1152/ajpendo.00401.2018 – ident: e_1_2_10_11_1 doi: 10.1373/clinchem.2011.176396 – ident: e_1_2_10_8_1 doi: 10.1016/j.cca.2019.11.016 – ident: e_1_2_10_6_1 doi: 10.1186/1471-2105-8-207 – ident: e_1_2_10_39_1 doi: 10.1038/nature11986 – ident: e_1_2_10_35_1 doi: 10.1021/ac402503m – ident: e_1_2_10_18_1 doi: 10.1016/j.metabol.2015.01.008 – ident: e_1_2_10_2_1 doi: 10.1038/nrg2918 – ident: e_1_2_10_38_1 doi: 10.1111/cen.14056 – ident: e_1_2_10_46_1 doi: 10.1021/ac202828r – ident: e_1_2_10_17_1 doi: 10.1109/TVCG.2015.2467771 – ident: e_1_2_10_23_1 doi: 10.1007/s00018-007-7053-7 – ident: e_1_2_10_52_1 doi: 10.1186/1741-7015-10-153 – ident: e_1_2_10_40_1 doi: 10.1016/j.mcna.2014.09.003 – ident: e_1_2_10_50_1 doi: 10.1186/1471-2393-14-11 – ident: e_1_2_10_33_1 doi: 10.1210/er.2015-1104 – ident: e_1_2_10_22_1 doi: 10.1353/pbm.1970.0001 – ident: e_1_2_10_12_1 doi: 10.1186/1752-0509-8-6 – ident: e_1_2_10_30_1 doi: 10.1038/s41573-019-0016-5 – ident: e_1_2_10_7_1 doi: 10.1016/j.metabol.2017.03.002 – volume: 11 start-page: S732 issue: 8 year: 2015 ident: e_1_2_10_20_1 article-title: Criteria and classification of obesity in Japan and Asia–Oceania publication-title: Asia Pacific Journal of Clinical Nutrition – ident: e_1_2_10_3_1 doi: 10.1016/j.fertnstert.2019.01.028 – ident: e_1_2_10_24_1 doi: 10.1055/s-0032-1328878 – ident: e_1_2_10_25_1 doi: 10.1186/s12863-015-0259-z – ident: e_1_2_10_10_1 doi: 10.1016/j.fertnstert.2004.11.070 – ident: e_1_2_10_43_1 doi: 10.1016/j.aca.2014.11.009 – ident: e_1_2_10_48_1 doi: 10.1016/j.febslet.2009.03.001 – ident: e_1_2_10_51_1 doi: 10.1016/j.freeradbiomed.2015.05.013 – ident: e_1_2_10_5_1 doi: 10.1021/ac051495j – ident: e_1_2_10_19_1 doi: 10.1210/jc.2012-1382 – ident: e_1_2_10_45_1 doi: 10.1038/nm.2307 – ident: e_1_2_10_4_1 doi: 10.1007/s10815-013-0004-3 – ident: e_1_2_10_42_1 doi: 10.1016/j.mce.2017.06.026 – ident: e_1_2_10_13_1 doi: 10.1186/1752-0509-5-1 – ident: e_1_2_10_49_1 doi: 10.1097/MD.0000000000004526 – ident: e_1_2_10_41_1 doi: 10.1186/cc3818 – ident: e_1_2_10_16_1 doi: 10.1002/bmc.4133 – ident: e_1_2_10_29_1 doi: 10.1038/ki.2010.333 – ident: e_1_2_10_14_1 doi: 10.1016/j.metabol.2018.11.002 – ident: e_1_2_10_44_1 doi: 10.1016/j.bbrc.2014.06.089 – ident: e_1_2_10_21_1 doi: 10.1210/jcem.87.2.8199 – ident: e_1_2_10_26_1 doi: 10.1016/j.jsbmb.2018.08.008 – ident: e_1_2_10_47_1 doi: 10.1186/1477-7827-9-7 – ident: e_1_2_10_15_1 doi: 10.1097/GRF.0b013e31802f54c8 – ident: e_1_2_10_37_1 doi: 10.1186/s12958-019-0490-y – ident: e_1_2_10_9_1 doi: 10.1530/EJE-14-0253 – ident: e_1_2_10_31_1 doi: 10.1038/s41591-019-0509-0 – ident: e_1_2_10_36_1 doi: 10.1021/pr3000317 – ident: e_1_2_10_32_1 doi: 10.1016/j.fertnstert.2008.09.070 – ident: e_1_2_10_28_1 doi: 10.1093/humupd/dmq001 |
SSID | ssj0009627 |
Score | 2.427159 |
Snippet | Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e4993 |
SubjectTerms | amino acid metabolism l‐tryptophan l‐tyrosine network analysis PCOS |
Title | Metabolomics and correlation network analysis of follicular fluid reveals associations between l‐tryptophan, l‐tyrosine and polycystic ovary syndrome |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fbmc.4993 https://www.ncbi.nlm.nih.gov/pubmed/32986877 https://www.proquest.com/docview/2447315132 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3Pa9swFMcfo4dtl61L9yNtN1Qo7WVOE8uWpWMXVkohO4wWCjsYSZZhzLXDkhSy0_6EXffv7S_pe5Kd0HWFslNwkK04epK_kr_6PID9rCjLNLUuItxblBRKRcako8jJ1GoaFpWjBf3JJ3F6kZxdppetq5L2wgQ-xGrBjXqGH6-pg2szO1pDQ82VHaBcJ9AnWbVID31ek6Mop0xYXlGEj1Udd3YYH3Un3n4S3ZGXt9Wqf9ycPIcv3Q8NLpNvg8XcDOyPvxiO_3cnm_CsVaHsOITNC3jk6h5sHdc4A79asgPmfaF-wb0HT8ZdTrgePJ60r-K34PfEzTGAKtrVPGO6LpilRB_BWsfq4C7H7wPzhDUlK4n_7W2vrKwWXwtG9CiMfqbXITJjrXGMVX9-_sI6pwQ-0PX7cLzEfxJr99VNm2ppl4SZZs013jzr4Asv4eLk4_n4NGrzPESWxyMeZYlxOJk1NpE4-khJ24m1sJ6-lthMFNzKVCQjO0QxJ20suDfvDMtUaRyjOH8FG3VTuzfAMueM1EKJMsGJfxGrMsmMGJrUcu4KLvtw2LV5blsIOuXiqPKAb45zbIycGqMPe6uS0wD--FeZLmxybAh61aJr1yxmOYqmjKOY4nEfXod4Wl2Fx0oKmWV9OPBRce_l8w-TMX1uP7TgDjyNyXLjLXK7sDH_vnBvUTPNzTvfO24A6K0W5Q |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb9NAEMdHpUiUC4-U0vBcJFQuOE289npXnEqgClD3gFqpByTLu15LCNeOmgQpnPgIXPl6fBJmdu1E5SEhTpGjtTfOzqxnx__9DcDTpCjLODY2INxbEBVKBVrHo8DK2OQ0LSpLCf30WExOo7dn8dkGvOj2wng-xCrhRp7h5mtycEpI76-pofrcDDBe51fgKhX0Jq989X7NjqKqMj7Bogggqzry7DDc7868_Cz6LcC8HK-6B87hTfjQ_VSvM_k0WMz1wHz5heL4n_dyC260gSg78JZzGzZs3YPtgxoX4edLtsecNNTl3HuwNe7KwvXgWtq-jd-G76mdow1VtLF5xvK6YIZqfXh1Hau9wBy_99gT1pSsJAS4U76yslp8LBgBpNABWL62khlrtWOs-vH1G_Y5JfZBXj_3x0v8K7F31920qZZmSaRp1nzGu2cdf-EOnB6-PhlPgrbUQ2B4OOJBEmmL61ltIokTkJS0ozgXxgHYIpOIghsZi2hkhhjPSRMK7vQ7wzJWOU5TnO_AZt3UdhdYYq2WuVCijHDtX4SqjBIthjo2nNuCyz486wY9My0HncpxVJknOIcZDkZGg9GHJ6uWU8_--FObzm4yHAh625LXtlnMMoybEo7xFA_7cNcb1OoqPFRSyCTpw54zi79ePnuZjunz3r82fAxbk5P0KDt6c_zuPlwPSYHjFHMPYHN-sbAPMYSa60fOVX4CK5wa_g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bb9MwFMePYEiDFwYdgzIuRkLjhXRpnDjO4-ioxqUTQkyaxEMUO7aEyJKKtkjliY_A677ePgnn2EmrcZEQT1Eix07iY_vY-ft3AJ6mpbVJok1AuLcgLrMsUCoZBkYmuqBuMTO0oD85Fkcn8evT5LRVVdJeGM-HWC24Uctw_TU18Glp99fQUHWmB-iu86twLRahpInX4fs1OoqCyvj1lYz4sVkHng2j_e7Oy0PRb_7lZXfVjTfjLfjYPamXmXweLOZqoL_9AnH8v1e5BTdbN5QdeLu5DVdM3YPtgxqn4GdLtsecMNStuPfg-qgLCteDzUn7L34bzidmjhZU0bbmGSvqkmmK9OG1daz28nK87qEnrLHMEgDc6V6ZrRafSkb4KDR_VqxtZMZa5RirLr7_wDKnRD4o6uf-fIlfEkt3xU2baqmXxJlmzVd8edbRF-7Ayfjlh9FR0AZ6CDSPhjxIY2VwNqt0LLH7kZL2ExdCO_xarFNRci0TEQ91iN6c1JHgTr0T2iQrsJPifAc26qY294ClxihZiEzYGGf-ZZTZOFUiVInm3JRc9uFZV-e5binoFIyjyj2_OcqxMnKqjD48WaWcevLHn9J0ZpNjRdC_lqI2zWKWo9eUcvSmeNSHu96eVrnwKJNCpmkf9pxV_DX7_MVkRMf7_5rwMWy-Oxznb18dv9mFGxHJb5xc7gFszL8szEP0n-bqkWsoPwHygRm2 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolomics+and+correlation+network+analysis+of+follicular+fluid+reveals+associations+between+l-tryptophan%2C+l-tyrosine+and+polycystic+ovary+syndrome&rft.jtitle=Biomedical+chromatography&rft.au=Hou%2C+Entai&rft.au=Zhao%2C+Yue&rft.au=Hang%2C+Jing&rft.au=Qiao%2C+Jie&rft.date=2021-03-01&rft.issn=1099-0801&rft.eissn=1099-0801&rft.volume=35&rft.issue=3&rft.spage=e4993&rft_id=info:doi/10.1002%2Fbmc.4993&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-3879&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-3879&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-3879&client=summon |